In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product.. In a unanimous ruling Thursday, the state ...

Most of the Delaware lawsuits claim Zantac caused types of cancer, including prostate, breast and colorectal cancer, that plaintiffs' lawyers dropped from the federal litigation in order to focus ...

The Delaware Zantac ruling, if it survives on appeal, is arguably a bigger problem for mass tort defendants than lawsuits in California or Illinois state courts.

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer.

Zantac was a once-popular antacid that has drawn a flurry of US personal-injury lawsuits alleging it causes cancer. Sanofi has said it faces about 25,000 cases in Delaware – significantly fewer than ...

The resulting influx of cases could have significant consequences for the efficient administration of justice in Delaware, for both Delaware-domiciled companies and Delaware residents, the ...

By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that ...